Ophthalmic Business News

Astellas Pharma has entered into a definitive agreement to acquire Iveric Bio for $40 per share in cash, for a total equity value of approximately $5.9 billion, Astellas announced in a press release.

Bausch + Lomb launched StableVisc and the TotalVisc viscoelastic system in the United States, according to a press release.

Among the various types of liability that physicians may face, including employee claims, HIPAA violations, cyber liability and slip-and-fall injuries, medical malpractice may be the most impactful.

TAMPA, Fla. — In this presentation from the Telling It Like It Is meeting, Albert Cheung, MD, discusses identifying indications for and performing ocular surface reconstruction.

Johnson & Johnson Vision received 510(k) clearance from the FDA for the Elita femtosecond laser for the creation of LASIK flaps, according to a press release.

Even in a highly developed country such as the United States, eye care access is not a reality for many people.

The FDA granted agreement under a special protocol assessment for the design of a clinical trial investigating risuteganib for the treatment of intermediate dry age-related macular degeneration, according to Allegro Ophthalmics.

The FDA cleared an investigational new drug application for AVD-104 for the treatment of geographic atrophy secondary to age-related macular degeneration, Aviceda Therapeutics announced in a press release.

Today’s economic environment and market volatility have caused many DIY investors to reconsider working with professional financial advisors. Those who work with advisors also may be evaluating their advisor and investigating alternatives.

Johnson & Johnson Vision announced changes to its leadership, with three executives taking on roles as regional presidents, according to a press release.